天津发展附属斥资3000万元认购兴业银行理财产品

Core Viewpoint - Tianjin Development (00882) announced a new investment agreement involving its indirect non-wholly owned subsidiary, Lifesun Pharmaceutical (002393), which will invest in a fixed-income product through a financial agreement with Xingyin Wealth Management and Industrial Bank [1] Group 1 - Lifesun Pharmaceutical has entered into its eleventh financial agreement with Industrial Bank, committing a principal amount of RMB 30 million, equivalent to approximately HKD 32.82 million [1]